NGS to Reduce Infectious Disease Diagnosis from 33 Days to 3 — Clinical Application Imminent

2025.07.01

Lung Cancer Monitoring with CTC Liquid Biopsy: Dow Biomedica Highlights Innovative Technology"

2025.06.25

Dow Biomedica Introduces ‘Shield’ Colorectal Cancer Screening Test to Korean Market

2025.06.17

SNU Hospital Team Suggests Blood Test Could Identify High-Risk Gastric Cancer Patients Early

2025.05.26

Bladder Cancer Prone to Recurrence Can Now Be Monitored Through Genetic Testing

2025.05.20

Dow Biomedica Unveils Non-Invasive Genetic Test for Early Detection of Kidney Transplant Complications

2025.05.07

Advanced MRD Detection Marks New Era in Precision Diagnostics for Multiple Myeloma

2025.04.24

Dowbiomedica introduce CTC Testing at the KSLM Conference

2025.04.17

A New Era in Atrophic Gastritis Screening Without Biopsy

2025.03.28

Introducing CTC Test at the Spring Conference of the Korean Society for Diagnostic Hematology

2025.03.18

Our CEO Honored with the 2025 Rookie Poet Award

2025.03.06

Launch of a Cancer Survivor Follow-Up Management Platform in Korea

2025.01.27